BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1517758)

  • 1. Immunohistochemical expression of microtubule-associated protein 5 (MAP5) in glial cells in multiple system atrophy.
    Arai N; Nishimura M; Oda M; Morimatsu Y; Ohe R; Nagatomo H
    J Neurol Sci; 1992 May; 109(1):102-6. PubMed ID: 1517758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems.
    Inoue M; Yagishita S; Ryo M; Hasegawa K; Amano N; Matsushita M
    Acta Neuropathol; 1997 Jun; 93(6):585-91. PubMed ID: 9194897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodendroglial and neuronal inclusions in multiple system atrophy.
    Costa C; Duyckaerts C
    Curr Opin Neurol; 1993 Dec; 6(6):865-71. PubMed ID: 8293161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitinated alpha B-crystallin in glial cytoplasmic inclusions from the brain of a patient with multiple system atrophy.
    Tamaoka A; Mizusawa H; Mori H; Shoji S
    J Neurol Sci; 1995 Apr; 129(2):192-8. PubMed ID: 7608736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).
    Papp MI; Kahn JE; Lantos PL
    J Neurol Sci; 1989 Dec; 94(1-3):79-100. PubMed ID: 2559165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoskeletal protein abnormalities in patients with olivopontocerebellar atrophy--an immunocytochemical and Gallyas silver impregnation study.
    Kobayashi K; Miyazu K; Katsukawa K; Fukutani Y; Mukai M; Nakamura I; Yamaguchi N; Matsubara R; Isaki K
    Neuropathol Appl Neurobiol; 1992 Jun; 18(3):237-49. PubMed ID: 1630577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple system atrophy.
    Quinn N; Wenning G
    Curr Opin Neurol; 1995 Aug; 8(4):323-6. PubMed ID: 7582051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiple system atrophy (MSA)].
    Moriwaka F; Tashiro K
    Nihon Rinsho; 1993 Nov; 51(11):2952-6. PubMed ID: 8277576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodendroglial and neuronal cytoplasmic inclusions in multisystem atrophy.
    Horoupian DS
    Prog Brain Res; 1992; 94():423-8. PubMed ID: 1287727
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuronal cell loss of the striatonigral system in multiple system atrophy.
    Kume A; Takahashi A; Hashizume Y
    J Neurol Sci; 1993 Jul; 117(1-2):33-40. PubMed ID: 8410064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple system atrophy.
    Quinn N; Wenning G
    Br J Hosp Med; 1994 May 4-17; 51(9):492-4. PubMed ID: 7921508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oligodendroglial inclusions, a marker of multisystemic atrophies].
    Costa C; Duyckaerts C; Cervera P; Hauw JJ
    Rev Neurol (Paris); 1992; 148(4):274-80. PubMed ID: 1332174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple system atrophy: a review of 203 pathologically proven cases.
    Wenning GK; Tison F; Ben Shlomo Y; Daniel SE; Quinn NP
    Mov Disord; 1997 Mar; 12(2):133-47. PubMed ID: 9087971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study.
    Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
    J Neurol Sci; 1996 Dec; 144(1-2):77-83. PubMed ID: 8994107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology.
    Papp MI; Lantos PL
    Brain; 1994 Apr; 117 ( Pt 2)():235-43. PubMed ID: 8186951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytoskeletal proteins abnormalities in olivopontocerebellar atrophy].
    Kobayashi K; Miyazu K; Katsukawa K; Fukutani Y; Mukai M; Nakamura I; Yamaguchi N; Matsubara R; Isaki K
    No To Shinkei; 1992 Mar; 44(3):249-58. PubMed ID: 1591102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple system atrophy.
    Kulczycki J
    Folia Neuropathol; 1997; 35(4):209-13. PubMed ID: 9833397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-field MR findings of multiple system atrophy].
    Tsuchiya K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jul; 50(7):772-9. PubMed ID: 2235325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of substance P in the substantia nigra of multiple system atrophy.
    Nomura H; Konno H; Takase S; Saito H
    Regul Pept; 1993 Jul; 46(1-2):247-50. PubMed ID: 7692506
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of neuronal degeneration of multiple system atrophy].
    Yoshida M; Sone M
    Brain Nerve; 2009 Sep; 61(9):1051-60. PubMed ID: 19803404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.